PTC Therapeutics Reports Strong Q3 2024 Performance
PTC Therapeutics ( (PTCT) ) has released its Q3 earnings. Here is a breakdown of the information PTC Therapeutics presented to its investors.
PTC announces $2B share repurchase program
PTC (PTC) announced that its Board of Directors has authorized the repurchase of up to $2B worth of PTC common stock through September 30, ...